These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
828 related articles for article (PubMed ID: 30244167)
1. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy. Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167 [TBL] [Abstract][Full Text] [Related]
2. Highly efficacious and specific anti-glioma chemotherapy by tandem nanomicelles co-functionalized with brain tumor-targeting and cell-penetrating peptides. Zhu Y; Jiang Y; Meng F; Deng C; Cheng R; Zhang J; Feijen J; Zhong Z J Control Release; 2018 May; 278():1-8. PubMed ID: 29596873 [TBL] [Abstract][Full Text] [Related]
3. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641 [TBL] [Abstract][Full Text] [Related]
4. Brain targeting effect of camptothecin-loaded solid lipid nanoparticles in rat after intravenous administration. Martins SM; Sarmento B; Nunes C; Lúcio M; Reis S; Ferreira DC Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):488-502. PubMed ID: 23994244 [TBL] [Abstract][Full Text] [Related]
6. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide. Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217 [TBL] [Abstract][Full Text] [Related]
8. Amphetamine decorated cationic lipid nanoparticles cross the blood-brain barrier: therapeutic promise for combating glioblastoma. Saha S; Yakati V; Shankar G; Jaggarapu MMCS; Moku G; Madhusudana K; Banerjee R; Ramkrishna S; Srinivas R; Chaudhuri A J Mater Chem B; 2020 May; 8(19):4318-4330. PubMed ID: 32330214 [TBL] [Abstract][Full Text] [Related]
9. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment. Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628 [TBL] [Abstract][Full Text] [Related]
10. Angiopep-2 and activatable cell-penetrating peptide dual-functionalized nanoparticles for systemic glioma-targeting delivery. Gao H; Zhang S; Cao S; Yang Z; Pang Z; Jiang X Mol Pharm; 2014 Aug; 11(8):2755-63. PubMed ID: 24983928 [TBL] [Abstract][Full Text] [Related]
11. Overcoming the Blood-Brain Tumor Barrier with Docetaxel-Loaded Mesoporous Silica Nanoparticles for Treatment of Temozolomide-Resistant Glioblastoma. Hsu TI; Chen YP; Zhang RL; Chen ZA; Wu CH; Chang WC; Mou CY; Chan HW; Wu SH ACS Appl Mater Interfaces; 2024 May; 16(17):21722-21735. PubMed ID: 38629735 [TBL] [Abstract][Full Text] [Related]
13. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery. Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890 [TBL] [Abstract][Full Text] [Related]
14. Arginine-Glycine-Aspartic Acid-Modified Lipid-Polymer Hybrid Nanoparticles for Docetaxel Delivery in Glioblastoma Multiforme. Shi K; Zhou J; Zhang Q; Gao H; Liu Y; Zong T; He Q J Biomed Nanotechnol; 2015 Mar; 11(3):382-91. PubMed ID: 26307822 [TBL] [Abstract][Full Text] [Related]
15. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting. Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519 [TBL] [Abstract][Full Text] [Related]
16. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
17. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
18. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment. van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797 [TBL] [Abstract][Full Text] [Related]
19. RVG29-modified docetaxel-loaded nanoparticles for brain-targeted glioma therapy. Hua H; Zhang X; Mu H; Meng Q; Jiang Y; Wang Y; Lu X; Wang A; Liu S; Zhang Y; Wan Z; Sun K Int J Pharm; 2018 May; 543(1-2):179-189. PubMed ID: 29555442 [TBL] [Abstract][Full Text] [Related]
20. Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment. Gao H; Yang Z; Cao S; Xiong Y; Zhang S; Pang Z; Jiang X Biomaterials; 2014 Feb; 35(7):2374-82. PubMed ID: 24342723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]